| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/01/2011 | US7879913 treating nicotine craving or nicotine withdrawal symptoms in a human by administering a therapeutically effective dose of iptakalim hydrochloride to the human |
| 02/01/2011 | US7879912 Process for preparing 3,3-diarylpropylamines |
| 02/01/2011 | US7879911 2-(4-Fluorophenoxy-N-hydroxyacetamide where the "oxy" can also be sulfonyl, sulfamyl or sulfinyl; enzyme inhibitors of the "lethal factor" enzyme released by bacillus anthraci that splits an essential peptide needed by mammals for signal transmission; antidotes; biological warfare |
| 02/01/2011 | US7879910 Compositions and methods for promoting lush hair growth |
| 02/01/2011 | US7879909 treating diabetic neuropathic foot ulcer by administering to subject an effective amount of Treprostinil or derivative or salt thereof, where derivative is sustained release, inhaled, or oral form or acid derivative, where subject has diabetic neuropathy but not peripheral vascular disease |
| 02/01/2011 | US7879908 reducing number of episodes of postinfarction heart failure in patients by intravenously administering L-carnitine or salt thereof within 6 hours of onset of symptoms of acute myocardial infarction to patients in need thereof, at an initial dose of 9 grams a day, in combination with glucose solution |
| 02/01/2011 | US7879907 Peroxisome Proliferator-Activated Receptor (PPAR) activators such as 3-{4-[3-(4-benzyloxy-3-methoxyphenyl)propyl]-3-butoxyphenyl}propanoic acid, used in dermatology, cosmetics, cardiovascular diseases, immunology and/or lipid metabolism |
| 02/01/2011 | US7879905 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 02/01/2011 | US7879904 9, 10-α,α-OH-taxane analogs and methods for production thereof |
| 02/01/2011 | US7879902 Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof |
| 02/01/2011 | US7879901 Sublingual Formulations of Ketorolac or Salts Thereof |
| 02/01/2011 | US7879900 Antiinflammatory agents; antitumor agents; Alzheimer's disease;atherosclerosis |
| 02/01/2011 | US7879899 Injectable veterinary composition for small animals |
| 02/01/2011 | US7879898 Hepatocyte growth factor pathway activators in chronic obstructive pulmonary disease |
| 02/01/2011 | US7879897 Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives |
| 02/01/2011 | US7879896 Dual-acting imidazole antihypertensive agents |
| 02/01/2011 | US7879895 Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
| 02/01/2011 | US7879894 Delivery to inflamed tissue by injection, implantation, or transdermal patch; prevention of pro-inflammatory cytokines will reduce and/or alleviate inflammation of tendons and soft tissue around carpal and tarsal tunnels; reducing compression of the median nerve and posterior tibial nerve, respectively |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879892 Anti-cancer and anti-microbial oxazolidinones |
| 02/01/2011 | US7879891 Caspase inhibitor prodrugs |
| 02/01/2011 | US7879890 hydantoin derivatives that can inhibit matrix metalloproteinases and tumor necrosis factor alpha-converting enzyme, to prevent the release of tumor necrosis factor; treatment of septic shock, reperfusion injuries, meningitis, psoriasis, arthritis, inflammatory bowel disease and ankylosing spondylitis |
| 02/01/2011 | US7879889 Therapeutic use of acylaminothiazole derivatives |
| 02/01/2011 | US7879888 Thiazole derivatives and use thereof |
| 02/01/2011 | US7879887 such as 2-(4-chloro-3-hydroxyphenylamino)-N-(6H-pyrazolo[4',3':3,4]benzo[1,2-d]thiazol-2-yl)-acetamide, having antitumor activity, particularly dual inhibitory activity on Aurora kinase and cyclin-dependent kinase (CDK), and are useful for cell proliferative diseases such as cancer |
| 02/01/2011 | US7879886 such as N-benzyl-N-hydroxy-2-(3-hydoxypyridin-2-ene)-1,3-thiazolidine-4-carboxamide, used for reducing the population of Plasmodium in a human infested with Plasmodium protozoans and suffering from malaria |
| 02/01/2011 | US7879885 Thioalkeneamides as transketolase inhibitors |
| 02/01/2011 | US7879884 Aryl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents |
| 02/01/2011 | US7879882 Thiazolyl mglur5 antagonists and methods for their use |
| 02/01/2011 | US7879881 Piperidinyl compounds that selectively bind integrins |
| 02/01/2011 | US7879880 Substituted aniline derivatives useful as histamine H3 antagonists |
| 02/01/2011 | US7879879 Biphenyl derivatives |
| 02/01/2011 | US7879878 Quinolone derivative or salt thereof |
| 02/01/2011 | US7879877 Carbostyril derivatives for accelerating salivation |
| 02/01/2011 | US7879876 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 02/01/2011 | US7879875 such as 6-(2,4-difluorophenyl)-1-[2-fluoro-5-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]-2H-quinolizin-2-one, used as antipyretics, analgesics, or in the treatment of arthritis, osteoarthritis, eczema, psoriasis and vision defects |
| 02/01/2011 | US7879874 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/01/2011 | US7879873 Chemotactic Cytokine Receptor 1 (CCR1) antagonists such as 1-(4-Fluorophenyl)-1H-pyrazolo[3,4-c]pyridine-4-carboxylic acid (5-methylamino-1,3,4-thiadiazol-2-ylmethyl)-amide, useful for treating autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis |
| 02/01/2011 | US7879872 Compositions comprising multiple bioactive agents, and methods of using the same |
| 02/01/2011 | US7879871 Crystalline forms of tiotropium bromide |
| 02/01/2011 | US7879870 Treatment of inflammatory and ulcerative diseases of the bowel with opioid antagonists |
| 02/01/2011 | US7879869 Drugs for ameliorating postcibal hyperglycemia |
| 02/01/2011 | US7879868 Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (BCRP)-mediated resistance to therapeutic agents |
| 02/01/2011 | US7879867 Crystalline antifungal compounds |
| 02/01/2011 | US7879866 Without stimulating calcium influx into cells; using such as N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide |
| 02/01/2011 | US7879865 central nervous system disorders; brain cancer; oral administration |
| 02/01/2011 | US7879864 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879862 Central nervous system disorders; psychological disorders; anxiolytic agents; irritable bowel syndrome; antidepressants |
| 02/01/2011 | US7879861 4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine, capable of both inhibiting epidermal growth factor receptors and damaging DNA; antitumor and antiproliferative agents |
| 02/01/2011 | US7879860 Variations in melting points, hygroscopicities, solubilities, flow properties and/or thermodynamic stabilities |
| 02/01/2011 | US7879859 Diagnosis and treatment of type 2 diabetes and other disorders |
| 02/01/2011 | US7879858 Substituted tetrahydropyrrolopyrazine compounds and the use thereof in pharmaceutical compositions |
| 02/01/2011 | US7879857 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors |
| 02/01/2011 | US7879856 Diaminothiazoles useful as Axl inhibitors |
| 02/01/2011 | US7879855 administering (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide, for the treatment of cancers of the colon, lung, ovary, and pancreas; anticarcinogenic agents |
| 02/01/2011 | US7879854 2-morpholin-4-ylethyl 5-[3-[(2S)-1-[4-(1-hydroxyhexyl)phenyl]-5-oxopyrrolidin-2-yl]propyl]thiophene-2-carboxylate, useful in treating vision defects, inflammatory bowel disease and alopecia |
| 02/01/2011 | US7879853 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 02/01/2011 | US7879852 Melanocortin receptor agonists |
| 02/01/2011 | US7879851 Viral polymerase inhibitors |
| 02/01/2011 | US7879850 Organic compounds |
| 02/01/2011 | US7879849 such as 1-(2-Methylpropyl)-2-propyl-2H-pyrazolo[3,4-c]quinolin-4-amine, used as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of viral and neoplastic diseases |
| 02/01/2011 | US7879848 Dipeptidyl Peptidase-IV inhibiting compounds, method of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 02/01/2011 | US7879847 such as 4-(5,6-Dihydro-8H-imidazo[5,1-c][1,4]oxazin-5-yl)benzonitrile, having aldosterone synthase and/or 11- beta -hydroxylase inhibitory activity, used for the treatment of hypertension and Cushing's Syndrome |
| 02/01/2011 | US7879846 Serine hydrolase inhibitors |
| 02/01/2011 | US7879845 Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors |
| 02/01/2011 | US7879844 Heterocyclic janus kinase 3 inhibitors |
| 02/01/2011 | US7879843 Benzothiazin-3-one compound and intermediate therefor |
| 02/01/2011 | US7879842 Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 02/01/2011 | US7879841 crystal structured 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride, used for the treatment of angina pectoris, myocardial infarct, and congestive heart failure; bradycardial agents |
| 02/01/2011 | US7879840 Ryanodine receptors (RyRs) modulators comprising 1,4-benzothiazepine derivatives, that regulate calcium channel functioning in cells, used for the treatment of cardiovascular disorders and muscular disorders |
| 02/01/2011 | US7879839 For treatment and prevention of cardiac arrhythmias; (+-)-2-Morpholin-4-yl-2-phenyl-1,1-dipyridin-3-yl-ethanol; (+-)-2-[(2-methoxyethyl)(methyl)amino]-2-phenyl-1,1-dipyridin-3-ylethanol |
| 02/01/2011 | US7879838 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 02/01/2011 | US7879837 Therapeutic or prophylactic agent for multiple sclerosis |
| 02/01/2011 | US7879836 treatment of hyperphagia comprising the administering 1-(3-chlorophenyl)-3-alkylpiperazine derivatives such as 1-(3-chlorophenyl)-3-ethylpiperazine; anorexigenic agents |
| 02/01/2011 | US7879835 Pharmaceutical composition for preventing and treating metabolic bone diseases containing alpha-arylmethoxyactylate derivatives |
| 02/01/2011 | US7879834 Spiroindoline modulators of muscarinic receptors |
| 02/01/2011 | US7879833 comprising a fixed combination of active compounds consisting of the active compound ciclesonide or an epimer thereof and the active compound R,R-formoterol or a salt, in an administration form suitable for inhalative administration by means of a powder inhaler; treatment of bronchitis, asthma |
| 02/01/2011 | US7879832 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 02/01/2011 | US7879831 Enhanced drug delivery in transdermal systems |
| 02/01/2011 | US7879830 Hormone replacement composition and method |
| 02/01/2011 | US7879829 19-nor-vitamin D analogs with 1,2-dihydrofuran ring |
| 02/01/2011 | US7879828 Carbohydrate, and an acid or buffer; improved stability in both solid and solution states |
| 02/01/2011 | US7879827 such as 5-amino-2-(2-Acetylamino-3-mercapto-propionyloxy)-benzoic acid, useful for the treatment of gastrointestinal disorders such as inflammatory bowel disease and irritable bowel syndrome, and for the prevention/treatment of colon cancer |
| 02/01/2011 | US7879826 N-methyl-D-aspartate (NMDA) receptor antagonists, such as Diethyl 3,3'-[({2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl}phosphoryl)bis(oxy)]dibenzoate, used for treating pain in a mammals; analgesics |
| 02/01/2011 | US7879825 N-methyl-D-aspartate (NMDA) receptor antagonists, such as 3-{2-[8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl]ethyl)-3-oxido-7-oxo-7-phenyl-2,4,6-trioxa-3-phosphahept-1-yl benzoate, used for treating pain ; analgesics |
| 02/01/2011 | US7879824 Administering oligosaccarhides, polysaccharides, and/or glycoaminoglycans for treatment of diseases/conditions associated with allergies, autoimmunity, the adhesion cascade, or metastasis |
| 02/01/2011 | US7879822 form a complex between sulforaphane, or analog thereof, and cyclodextrin |
| 02/01/2011 | US7879821 Method for modulating inflammatory responses by altering plasma lipid levels |
| 02/01/2011 | US7879820 Opalescent mixtures of water, surfactants and cyclodextrins, used as shampoo, bleaches, hair conditioners or dyes |
| 02/01/2011 | US7879818 biodegradability; stable in aqueous media, may be used as detergents and additives for pharmaceutical compositions for drug delivery, DNA carrier system; biopolymers for controlled release, super-absorbent materials and biomaterials like enzyme immobilization |
| 02/01/2011 | US7879817 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 02/01/2011 | US7879816 Methods of treating cancer and other conditions or disease states using LFMAU and LDT |
| 02/01/2011 | US7879815 Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
| 02/01/2011 | US7879814 Administering adenosine 5'-monophosphate; side effect reduction |
| 02/01/2011 | US7879813 Interfering RNA delivery system and uses thereof |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879809 Controlling ectoparasite infestations in aquaculture; adding spinosyn component to feed |
| 02/01/2011 | US7879808 Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient |